Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monga, S. P. S.
Right arrow Articles by Michalopoulos, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monga, S. P. S.
Right arrow Articles by Michalopoulos, G. K.
[Cancer Research 62, 2064-2071, April 1, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Hepatocyte Growth Factor Induces Wnt-independent Nuclear Translocation of ß-Catenin after Met-ß-Catenin Dissociation in Hepatocytes1

Satdarshan P. S. Monga, Wendy M. Mars, Peter Pediaditakis, Aaron Bell, Karen Mulé, William C. Bowen, Xue Wang, Reza Zarnegar and George K. Michalopoulos2

Division of Cellular and Molecular Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15261

Hepatocyte growth factor (HGF) and Wnt signaling pathways have been shown to be important in embryogenesis and carcinogenesis. The aim of this study was to elucidate the mechanism of functional similarities observed in the two pathways. We used normal rat liver, primary hepatocyte cultures and a dominant-negative Met expression system to study the effect of HGF on Wnt pathway components. We demonstrate novel association of ß-catenin and Met, a tyrosine kinase receptor of HGF, at the inner surface of the hepatocyte membrane. HGF induces dose-dependent nuclear translocation of ß-catenin in primary hepatocyte cultures that is Wnt independent. The source of ß-catenin for translocation in hepatocytes is the Met-ß-catenin complex, which appears to be independent of the E-cadherin-ß-catenin complex. To test the functionality of this association, we used a dominant-negative Met expression system that expresses only the extracellular and transmembrane regions of the ß-subunit of Met. A loss of Met-ß-catenin association resulted in abrogation of nuclear translocation of ß-catenin upon HGF stimulation. This event is tyrosine phosphorylation dependent, and the association of Met and ß-catenin is crucial for this event. We conclude that the HGF causes similar redistribution of ß-catenin as Wnt-1 in the hepatocytes and that this effect is attributable to subcellular association of Met and ß-catenin. The intracellular kinase domain of Met is essential for tyrosine phosphorylation and nuclear translocation of ß-catenin. Part of the multifunctionality of HGF might be attributable to nuclear ß-catenin and the resulting target gene expression.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
H. L. Palka-Hamblin, J. J. Gierut, W. Bie, P. M. Brauer, Y. Zheng, J. M. Asara, and A. L. Tyner
Identification of {beta}-catenin as a target of the intracellular tyrosine kinase PTK6
J. Cell Sci., January 15, 2010; 123(2): 236 - 245.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Goldoni, A. Humphries, A. Nystrom, S. Sattar, R. T. Owens, D. J. McQuillan, K. Ireton, and R. V. Iozzo
Decorin is a novel antagonistic ligand of the Met receptor
J. Cell Biol., May 18, 2009; 185(4): 743 - 754.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Jean, A. Blanc, N. Prade-Houdellier, L. Ysebaert, H. Hernandez-Pigeon, T. Al Saati, M.-J. Haure, A.-M.-L. Coluccia, M. Charveron, E. Delabesse, et al.
Epidermal Growth Factor Receptor/{beta}-Catenin/T-Cell Factor 4/Matrix Metalloproteinase 1: A New Pathway for Regulating Keratinocyte Invasiveness after UVA Irradiation
Cancer Res., April 15, 2009; 69(8): 3291 - 3299.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. D. David, A. Yeramian, M. Dunach, M. Llovera, C. Canti, A. G. de Herreros, J. X. Comella, and J. Herreros
Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential {beta}-catenin phosphorylation
J. Cell Sci., August 15, 2008; 121(16): 2718 - 2730.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
J. B. Litten and G. E. Tomlinson
Liver Tumors in Children
Oncologist, July 1, 2008; 13(7): 812 - 820.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Marsh, S. Dickinson, G. W. Neill, J. F. Marshall, I. R. Hart, and G. J. Thomas
{alpha}v{beta}6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation
Cancer Res., May 1, 2008; 68(9): 3295 - 3303.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. S. Gujral, W. van Veelen, D. S. Richardson, S. M. Myers, J. A. Meens, D. S. Acton, M. Dunach, B. E. Elliott, J. W.M. Hoppener, and L. M. Mulligan
A Novel RET Kinase-{beta}-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma
Cancer Res., March 1, 2008; 68(5): 1338 - 1346.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Ye, D. Hu, L. Tu, X. Zhou, F. Lu, B. Wen, W. Wu, Y. Lin, Z. Zhou, and J. Qu
Involvement of PI3K/Akt Signaling Pathway in Hepatocyte Growth Factor-Induced Migration of Uveal Melanoma Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. D. Tward, K. D. Jones, S. Yant, S. T. Cheung, S. T. Fan, X. Chen, M. A. Kay, R. Wang, and J. M. Bishop
Distinct pathways of genomic progression to benign and malignant tumors of the liver
PNAS, September 11, 2007; 104(37): 14771 - 14776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
U. Apte, G. Zeng, M. D. Thompson, P. Muller, A. Micsenyi, B. Cieply, K. H. Kaestner, and S. P. S. Monga
beta-Catenin is critical for early postnatal liver growth
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1578 - G1585.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Lutterbach, Q. Zeng, L. J. Davis, H. Hatch, G. Hang, N. E. Kohl, J. B. Gibbs, and B.-S. Pan
Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival
Cancer Res., March 1, 2007; 67(5): 2081 - 2088.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. R. Anderson, R. Harrison, P. A. Atherfold, M. J. Campbell, S. J. Darnton, J. Obszynska, and J. A.Z Jankowski
Met receptor signaling: a key effector in esophageal adenocarcinoma.
Clin. Cancer Res., October 15, 2006; 12(20): 5936 - 5943.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Peruzzi, G. Athauda, and D. P. Bottaro
The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells
PNAS, September 26, 2006; 103(39): 14531 - 14536.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Mazzone and P. M. Comoglio
The Met pathway: master switch and drug target in cancer progression
FASEB J, August 1, 2006; 20(10): 1611 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Nakaigawa, M. Yao, M. Baba, S. Kato, T. Kishida, K. Hattori, Y. Nagashima, and Y. Kubota
Inactivation of von Hippel-Lindau Gene Induces Constitutive Phosphorylation of MET Protein in Clear Cell Renal Carcinoma.
Cancer Res., April 1, 2006; 66(7): 3699 - 3705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-M. Xu, Y.-Q. Zhou, and M.-H. Wang
Mechanisms of Cytoplasmic {beta}-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase
J. Biol. Chem., July 1, 2005; 280(26): 25087 - 25094.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Welm, S. Kim, B. E. Welm, and J. M. Bishop
MET and MYC cooperate in mammary tumorigenesis
PNAS, March 22, 2005; 102(12): 4324 - 4329.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. M. Fischer, S. Giordano, P. M. Comoglio, and A. Ullrich
Reactive Oxygen Species Mediate Met Receptor Transactivation by G Protein-coupled Receptors and the Epidermal Growth Factor Receptor in Human Carcinoma Cells
J. Biol. Chem., July 9, 2004; 279(28): 28970 - 28978.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Slater, E. Koutsouki, C. L. Jackson, R. C. Bush, G. D. Angelini, A. C. Newby, and S. J. George
R-Cadherin:{beta}-Catenin Complex and Its Association With Vascular Smooth Muscle Cell Proliferation
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1204 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Graham and A. R. Asthagiri
Epidermal Growth Factor-mediated T-cell Factor/Lymphoid Enhancer Factor Transcriptional Activity Is Essential but Not Sufficient for Cell Cycle Progression in Nontransformed Mammary Epithelial Cells
J. Biol. Chem., May 28, 2004; 279(22): 23517 - 23524.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Wadham, J. R Gamble, M. A Vadas, and Y. Khew-Goodall
The Protein Tyrosine Phosphatase Pez Is a Major Phosphatase of Adherens Junctions and Dephosphorylates {beta}-Catenin
Mol. Biol. Cell, June 1, 2003; 14(6): 2520 - 2529.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al.
Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4
J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.